Constructing a PANoptosis-based prognostic signature to evaluate the immune landscape and therapeutic response in clear cell renal cell carcinoma
PANI provides precise prognosis and immunotherapy response predictions for ccRCC patients, facilitating individualized treatment strategies.
Authors
- Zhinan Xia
- Shenhao Xu
- Zitong Yang (ORCID: https://orcid.org/0000-0003-2886-0988)
- Liangliang Ren (ORCID: https://orcid.org/0000-0001-5232-8778)
- Jiahao Liao
- Zhiming Cui
- Yanru Wang (ORCID: https://orcid.org/0000-0001-8272-2450)
- Cheng Zhang
- Yu Dong (ORCID: https://orcid.org/0000-0002-2744-2701)
- Bing Liu
- Shuwen Wang
- Wei Guo
- Tengda Wang
Institutions
- Zhejiang International Studies University (CN)
- Zhejiang Chinese Medical University (CN)
- Harbin Medical University (CN)
- Zhejiang Cancer Hospital (CN)
- Fourth Affiliated Hospital of Harbin Medical University (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Guizhou Provincial People's Hospital (CN)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Zhejiang University SCIENCE B
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1631/jzus.b2400132
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00